Hepatitis C virus (HCV) is disproportionately prevalent among justice-involved populations, making correctional settings an important opportunity for screening, treatment, and connection to ongoing care. Despite highly effective curative therapies, barriers such as fragmented care, transitions between custody and the community, limited specialty access, co-occurring substance use and behavioral health conditions, and inconsistent follow-up can delay treatment and affect outcomes. This session will provide practical, evidence-based strategies to improve HCV screening, treatment, and continuity of care in correctional and reentry settings. Through expert instruction and case-based discussion, participants will explore approaches to overcoming common clinical and operational barriers, strengthening coordination between correctional and community providers, and supporting patients during reentry. The program will emphasize strategies that can be implemented across diverse settings to improve treatment completion, reduce ongoing transmission, and advance HCV elimination efforts for a high-risk population.

Educational Objectives:

• Identify barriers to hepatitis C screening, treatment, and continuity of care

• Apply evidence-based strategies to improve screening, linkage to care, and access to treatment 

• Develop multidisciplinary approaches to strengthen care coordination and support continuity of treatment following release

Supported by an independent medical grant from Gilead Sciences